Discontinued — last reported Q1 '22
Elevance Health Commercial Specialty Business — Total net incurred medical claims decreased by 10.8% to $6.83B in Q1 2022 compared to the prior quarter. This is a positive signal — lower values indicate better performance for this metric.
Used to calculate the Medical Loss Ratio; lower values relative to revenue indicate higher underwriting profitability.
This is the aggregate of all net medical claims incurred by the Commercial and Specialty segment, including both current...
Standard industry metric for total medical expense, comparable across all major health insurance carriers.
elv_segment_commercial_specialty_business_segment_total_net_incurred_medical_claims| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | |
|---|---|---|---|---|
| Value | $6.72B | $7.21B | $7.66B | $6.83B |
| QoQ Change | — | +7.4% | +6.3% | -10.8% |